Sennosides Tablet
Product Images NDC 62993-0001

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sennosides (NDC 62993-0001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Morepen Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Primary Display Panel 100 Tablets (100 Tablets Pdp)

Drug Facts panel for Sennosides Tablets 8.6 mg by Morepen Laboratories Limited. It includes active ingredient information, purpose, uses, warnings, directions by age group, other product information, and inactive ingredients. The label provides dosing instructions and safety warnings typical for a laxative product.*

FDA Label Image

Primary Display Panel 1000 Tablets (1000 Tablets Pdp)

Drug Facts panel and product label for Sennosides Tablets 8.6 mg by Morepen Laboratories Limited. The panel details active ingredients, purposes, warnings, directions for use by age group, inactive ingredients, storage instructions, and manufacturer contact information. The product contains 1000 tablets and is indicated for occasional constipation relief.*

FDA Label Image

Primary Display Panel 250 Tablets (250 Tablets Pdp)

Sennosides Tablets 8.6 mg packaging label by Morepen Laboratories Limited. The label shows 250 tablets and highlights the product as standardized Senna concentrate 8.6 mg for constipation relief. It includes the labeler's name, Morepen Bio Inc., with address, and a barcode. The label also has a security seal warning and dosage information.*

FDA Label Image

Primary Display Panel 30 Tablets (30 Tablets Pdp)

Sennosides Tablets 8.6 mg oral tablets packaged in a label showing Morepen Laboratories Limited as the labeler. The label indicates regular strength with 30 tablets per package and includes directions, warnings, drug facts, active ingredients, and storage information.*

FDA Label Image

Primary Display Panel 3000 Tablets (3000 Tablets Pdp)

Drug Facts panel for Sennosides Tablets 8.6 mg from Morepen Laboratories Limited details active ingredient and purpose, uses, warnings, dosage directions by age group, other information including excipients and storage, and contact information for questions or comments. The label also notes a package size of 3000 tablets.*

FDA Label Image

Active Ingredient Label (Active Ingredient)

Drug Facts label panel showing the active ingredient Sennosides at 8.6 mg per tablet and its purpose listed as laxative. The text is presented in a black and white boxed format with bold headers.*

FDA Label Image

Dosage & Administration (Dosage And Administration)

Directions panel showing dosing recommendations for Sennosides tablets by age group. It lists starting and maximum dosages for adults and children 12 years and over, children 6 to under 12 years, children 2 to under 6 years, and advises consulting a doctor for children under 2 years. The label advises taking preferably at bedtime or as directed by a doctor.*

FDA Label Image

Inactive Ingredients (Inactive Ingredient)

Label excerpt listing inactive ingredients for Sennosides tablets, including croscarmellose sodium, dibasic calcium phosphate, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, and polyethylene glycol.*

FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Reach Children)

A drug facts panel warning that reads: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.*

FDA Label Image

Purpose (Purpose)

A partial Drug Facts panel showing the active ingredient section for Sennosides tablets. It specifies each tablet contains 8.6 mg of Sennosides, listed as a laxative.*

FDA Label Image

Questions (Questions)

A text panel titled 'Question or comments?' providing a toll-free phone number (1-844-317-6549) available Monday to Friday from 9 AM to 5 PM EST, and instructions to contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch for further information or reports.*

FDA Label Image

Storage And Handling (Storage And Handling)

This image shows a drug facts panel titled 'Other information' for Sennosides tablets. It states that each tablet contains 26.9 mg of calcium and includes storage instructions recommending to store at 25°C (77°F) with permitted temperature excursions between 15-30°C (59-86°F).*

FDA Label Image

Indications & Usage (Uses)

Drug Facts panel titled Uses, indicating the product relieves occasional constipation (irregularity) and generally produces a bowel movement in 6-12 hours.*

FDA Label Image

Warnings (Warnings Section)

Drug facts warning panel for Sennosides oral tablets. It advises not to use laxatives for more than 1 week without doctor approval, to consult a doctor before use if experiencing stomach pain, nausea, vomiting, or significant changes in bowel habits. It instructs to stop use and seek medical advice if rectal bleeding occurs or bowel movements fail. Additional warnings include consulting a professional if pregnant or breastfeeding and keeping the product away from children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.